Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline
Isabelle Bedrosian, Mark R. Somerfield, Maria Isabel Achatz, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 5, pp. 584-604
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline
Nadine Tung, Charité Ricker, Hans Messersmith, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 21, pp. 2599-2615
Closed Access | Times Cited: 24
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline
Evan Y. Yu, R. Bryan Rumble, Neeraj Agarwal, et al.
Journal of Clinical Oncology (2025)
Closed Access | Times Cited: 2
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer (EBC): Update 2024
Tjoung‐Won Park‐Simon, Volkmar Müller, Ute-Susann Albert, et al.
Breast Care (2024) Vol. 19, Iss. 3, pp. 165-182
Open Access | Times Cited: 9
BRCA-mutated breast cancer: the unmet need, challenges and therapeutic benefits of genetic testing
Banu K. Arun, Fergus J. Couch, Jean Abraham, et al.
British Journal of Cancer (2024)
Open Access | Times Cited: 9
Taking the risk. A systematic review of ethical reasons and moral arguments in the clinical use of polygenic risk scores
Lara Andreoli, Hilde Peeters, Kristel Van Steen, et al.
American Journal of Medical Genetics Part A (2024) Vol. 194, Iss. 7
Closed Access | Times Cited: 6
Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers
Luca Arecco, Marco Bruzzone, R. Bas, et al.
Annals of Oncology (2024) Vol. 35, Iss. 9, pp. 792-804
Open Access | Times Cited: 6
Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy
Carla Apostolova, Amina Ferroum, Basmah Alhassan, et al.
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 6, pp. 108324-108324
Closed Access | Times Cited: 5
Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing.
Charlie F Rowlands, Sophie Allen, Judith Balmañà, et al.
Annals of Oncology (2024) Vol. 35, Iss. 10, pp. 892-901
Open Access | Times Cited: 5
BRCA genetic testing and counseling in breast cancer: how do we meet our patients’ needs?
Peter Dubsky, Christian Jackisch, Seock‐Ah Im, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Practices and perspectives of genetic counselors about high‐risk pancreatic cancer screening: A cross‐sectional survey study
Amy Wiegand, Ankit Chhoda, Aryan M. Namboodiri, et al.
Journal of Genetic Counseling (2025) Vol. 34, Iss. 1
Closed Access
Germline BRCA testing in Denmark following invasive breast cancer: Progress since 2000
A. Kostov, Maj‐Britt Jensen, Bent Ejlertsen, et al.
Acta Oncologica (2025) Vol. 64, pp. 147-155
Open Access
CHEK2-related breast cancer: real-world challenges
Luiza Nardin Weis, Brittany L. Bychkovsky, Adela Rodríguez Hernandez, et al.
Familial Cancer (2025) Vol. 24, Iss. 1
Closed Access
Pathogenic Germline Variants in Patients With Metaplastic Breast Cancer
Kaitlin Demarest, Arravinth Anantharajah, Kara N. Maxwell, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2460312-e2460312
Open Access
Breast, Colorectal, and Pancreatic Cancer Mortality With Pathogenic Variants in ATM , CHEK2 , or PALB2
Christine M. Veenstra, Paul Abrahamse, Ann S. Hamilton, et al.
Journal of Clinical Oncology (2025)
Closed Access
Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndrome
Giovanna Sighinolfi, Giovanni Grandi, Elena Barbieri, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Rethinking contralateral breast cancer: latest insights on risk, prevention, and outcomes
Mohammad‐Salar Hosseini
Clinical Cancer Bulletin (2025) Vol. 4, Iss. 1
Open Access
Unmet need for previously untreated metastatic triple-negative breast cancer: a real-world study of patients diagnosed from 2011 to 2022 in the United States
Kevin Punie, Allison W. Kurian, Ιωάννα Ντάλλα, et al.
The Oncologist (2025) Vol. 30, Iss. 3
Open Access
Prevalence and clinical impact of germline pathogenic variants in breast cancer: a descriptive large single-center study
A. Rodriguez-Hernandez, O. Martínez-Sáez, F. Brasó-Maristany, et al.
ESMO Open (2025) Vol. 10, Iss. 4, pp. 104543-104543
Open Access
NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors—A Retrospective Molecular Tumor Board Analysis
Niklas Gremke, Fiona R. Rodepeter, Julia Teply‐Szymanski, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1561-1561
Open Access | Times Cited: 4
Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline Clinical Insights
Charité Ricker, Banu K. Arun, Sara Pirzadeh‐Miller, et al.
JCO Oncology Practice (2024) Vol. 20, Iss. 10, pp. 1308-1313
Closed Access | Times Cited: 4
Society of Surgical Oncology Medical Student & Trainee Primer for Breast Surgical Oncology
Marissa K. Boyle, Julia M Selfridge, Rachel E. Sargent, et al.
Surgical Oncology Insight (2025), pp. 100129-100129
Open Access
Genetic counseling referral rates and genetic testing outcomes in women with young breast cancer: a 20-year Canadian review
Susan Randall Armel, Janet Malcolmson, Alexandra Volenik, et al.
Breast Cancer Research and Treatment (2025)
Closed Access
Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status
Matteo Lambertini, Eva Blondeaux, Loredana Maria Tomasello, et al.
Journal of Clinical Oncology (2025)
Closed Access
The role of artificial intelligence integrating multi-omics in breast cancer
Raquel Gómez Bravo, Benjamín Walbaum, Elia Seguí, et al.
Revista de Senología y Patología Mamaria (2025) Vol. 38, Iss. 3, pp. 100677-100677
Closed Access
Identifying Germline Pathogenic Variants in Breast Cancer Using Tumor Sequencing
Mara Cruellas, Andri Papakonstantinou, Adrià López‐Fernández, et al.
The Breast (2025) Vol. 81, pp. 104439-104439
Open Access
Page 1 - Next Page

Scroll to top